Crysalin was founded to research, develop and license crysalin lattice technology – a new area of protein-based nanotechnology. The technology is founded upon patented research conducted since 2002 in the Oxford University Laboratory of Molecular Biophysics. Crysalin lattice design principles allow for tailored crystal formation in 1-, 2- and 3- dimensions with repeating units on scales of approximately 1-100nm.
|
As at 31 Dec 2012 |
IP Group holding |
IP Venture Fund* holding |
25.1% |
11.1% |
|
*IP Group has a 10%
economic interest in IP
Venture Fund |
Holdings represent undiluted beneficial equity interest excluding debt